Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.

Accepted 2023-09-07 00:00:00 ET · period of report 2023-09-07 · accession 0001104659-23-098986 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-09-07	2023-09-07	SUPN	Bhatt Padmanabh P.	CSO, SVP of IP	F - Tax	$32.10	-1,182	7,165	-14%	-$37.9K
D	2023-09-07	2023-09-07	SUPN	Bhatt Padmanabh P.	CSO, SVP of IP	M - OptEx	$0.00	+2,500	8,347	+43%	$0
D	2023-09-07	2023-09-07	SUPN	Bhatt Padmanabh P.	CSO, SVP of IP	M - OptEx	$0.00	-2,500	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-09-07	F	D	1,182	$32.10	7,165	D	—	—	(F2) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the PSU vesting.
2	Common	Common Stock	2023-09-07	M	A	2,500	$0.00	8,347	D	—	—	(F1) Shares of common stock received upon the settlement of certain performance share units granted to the Reporting person on February 23, 2023.
3	Derivative	Performance Share Unit	2023-09-07	M	D	2,500	$0.00	0	D	$0.00 · — to —	2,500 Common Stock	(F1) Shares of common stock received upon the settlement of certain performance share units granted to the Reporting person on February 23, 2023. (F3) On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023.